ÂÒÂ×Ðã

We work with ÂÒÂ×Ðã Innovation & Enterprise and ÂÒÂ×Ðã Business (ÂÒÂ×ÐãB) to help commercialise research that will have a real and measurable impact on people’s lives.

Here are some examples of translational activity from within our healthcare engineering community.

Investment advances novel cell therapy for peripheral nerve repair

Hundreds of thousands of people every year are affected by severe peripheral nerve damage. A team from ÂÒÂ×Ðã Centre for Nerve Engineering have developed an off-the-shelf therapy and ÂÒÂ×Ðã spin-out, Glialign has received significant investment to take this work forward.

Read the case studyÌý

Odin Vision: space technology to fight bowel cancer

ÂÒÂ×Ðã spin-out company Odin Vision has received £1 million funding to use space technology to improve the early detection and diagnosis of bowel cancer.

Read the case study

Two deals help commercialise bioactive aerogels for dental applications

New technology developed at ÂÒÂ×Ðã for dental bone grafting and other biomedical applications uses bioactive aerogels.ÌýIn 2018, the team obtained funding for a study to gain CE mark approval to allow sales in Europe and, crucially, also obtained an agreement from a multinational commercial partner to co-develop the technology for regulatory approval.Ìý

Read the case study

Acceleration programmes

Conception X

Conception X is a venture builder for PhD students involved in AI/deep tech. The programme was launched at ÂÒÂ×Ðã but is open to all postgraduate students from any UK university.Ìý

P4 Precision Medicine

P4 Precision Medicine is an accelerator programme for early to mid-stage medical device, diagnostic and digital health companies. The programme is a partnership between ÂÒÂ×Ðã, Barclays and Capital Enterprise.Ìý

Ìý